Cargando…
Possible de novo clear cell carcinoma in the contralateral ovary 9 years after fertility-sparing surgery for Stage IA clear cell ovarian carcinoma
A patient who underwent fertility-sparing surgery for Stage IA clear cell carcinoma may have developed de novo clear cell carcinoma in the contralateral ovary 9 years later. She underwent fertility-sparing surgery and postoperative adjuvant chemotherapy for right ovarian carcinoma at 33 years of age...
Autores principales: | Nishida, K., Tenjimbayashi, Y., Tasaka, N., Shikama, A., Sakuraiv, M., Nakao, S., Ochi, H., Minaguchi, T., Satoh, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498281/ https://www.ncbi.nlm.nih.gov/pubmed/31149470 http://dx.doi.org/10.1007/s13691-016-0271-9 |
Ejemplares similares
-
Differential roles of the Wip1–p38–p53 DNA damage response pathway in early/advanced-stage ovarian clear cell carcinomas
por: Xu, Chenyang, et al.
Publicado: (2022) -
Safety of fertility-sparing surgery for stage I ovarian clear cell carcinoma
por: Park, Jeong-Yeol
Publicado: (2017) -
Abnormal accumulation of p53 predicts radioresistance leading to poor survival in patients with endometrial carcinoma
por: Akiyama, Azusa, et al.
Publicado: (2019) -
Expression of Tissue Factor in Epithelial Ovarian Carcinoma Is Involved in the Development of Venous Thromboembolism
por: Sakurai, Manabu, et al.
Publicado: (2017) -
Clinicopathological correlations of endometrioid and clear cell carcinomas in the uterus and ovary
por: Mori, Hidemi, et al.
Publicado: (2023)